Boston, MA (PRWEB) June 25, 2012
After the possibility to cryopreserve amniotic fluid stem cell, it will be possible to cryopreserve stem cells contained in Chorionic Villi collected during the prenatal diagnosis test of Chorionic Villus Sampling (CVS).
Chorionic Villi stem cells are fetal stem cells, pluripotent, with great characteristics in terms of proliferation, differentiation and genomic stability, being perfectly ethic at the same time.
Many international research groups are currently studying Chorionic Villi stem cells, that in the future might have a role in regenerative medicine and cellular therapy.
The service will be available thanks to a patent developed by Biocell Center Corporation - European biotech group based in Milan, Italy, with international branches in Medford, MA, USA, and Lugano, Switzerland - thanks to the last two years' researches. "We were able to come up with solutions for several technical and scientific issues - said Dr. Giuseppe Simoni, Biocell Center's Scientific Director - coming up with a method that allow us to obtain tremendous results in terms of quantity and viability of stem cells to cryopreserve."
The announcement, given during the exhibition BIO 2012 held this year in Boston - where Biocell Center have its facility and lab - was of great interest for the international scientific community.
"The hope - concluded Dr. Simoni - is that in the future this cells of the newborn might be used to regenerate tissues and cure diseases."
source: Biocell Center Corporation